Evidence map›Paper›PMID 37749097›Full record

ArticleNPJ vaccines2023

Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.

Shivankari Krishnananthasivam, Hao Li, Rania Bouzeyen, Bhuvaneshwari Shunmuganathan, Kiren Purushotorman, Xinlei Liao, Fengjiao Du, Claudia Guldager Kring Friis, Felicity Crawshay-Williams, Low Heng Boon and 11 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. A proteome-wide atlas of humoral immunity toFrontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Shivankari Krishnananthasivam *Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0001-7141-0590
Hao Li *College of Veterinary Medicine, China Agricultural University, Beijing, China.
Rania Bouzeyen *Division of Experimental Medicine, University of California, San Francisco, USA.
Bhuvaneshwari ShunmuganathanLife Sciences Institute, National University of Singapore, Singapore, Singapore.
Kiren PurushotormanLife Sciences Institute, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-6640-1144
Xinlei LiaoNational Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
Fengjiao DuNational Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
Claudia Guldager Kring FriisDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Felicity Crawshay-WilliamsMolecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.
Low Heng BoonDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Qian XinleiLife Sciences Institute, National University of Singapore, Singapore, Singapore.
Conrad En Zuo ChanNational Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.ORCID http://orcid.org/0000-0001-5730-7095
Radoslaw SobotaInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0002-2455-2526
Mary KozmaLife Sciences Institute, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4125-3130
Valeria BarcelliDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-0019-3271
Guirong WangNational Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
Hairong HuangNational Clinical Laboratory on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Institute, Beijing Chest Hospital, Capital Medical University, Beijing, P.R. China.
Andreas FlotoMolecular Immunity Unit, University of Cambridge, Department of Medicine, MRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0002-2188-5659
Pablo BifaniDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Babak JavidCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China. babak.javid@ucsf.edu.
Paul A MacAryDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. micpam@nus.edu.sg.ORCID http://orcid.org/0000-0002-1139-8996
National University of Singapore · SGCapital Medical University · CNMRC Laboratory of Molecular Biology · GBUniversity of California, San Francisco · USAgency for Science, Technology and Research · SGChina Agricultural University · CNTan Tock Seng Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37749097
PMCPMC10520079
OpenAlexW4387021797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.